Literature DB >> 508555

Fenamates may antagonize the actions of prostaglandin endoperoxides in human myometrium.

G J Sanger, A Bennett.   

Abstract

1 The prostaglandin endoperoxide analogue U-46619 potently contracted human isolated myometrium, suggesting that prostaglandin H2 (PGH2) may be a major stimulant of myometrial contractions. 2 Sodium mefenamate, flufenamate or meclofenamate 2 microgram/ml greatly reduced contractions of the myometrium induced by the PGH2 analogue. 3 Flufenamate, but not the other two drugs, also significantly inhibited contractions to acetylcholine. 4 Sodium meclofenamate 2 microgram/ml did not consistently antagonize contractions to PGF2alpha. 5 The relief of dysmenorrhoea by fenamates may be explained both by inhibition of PG synthesis, and by antagonism of contractions to PGH2 produced by incompletely blocked PG synthesis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 508555      PMCID: PMC1429819          DOI: 10.1111/j.1365-2125.1979.tb01030.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  18 in total

1.  PROSTAGLANDINS IN ENDOMETRIUM AND MENSTRUAL FLUID FROM NORMAL AND DYSMENORRHOEIC SUBJECTS.

Authors:  V R PICKLES; W J HALL; F A BEST; G N SMITH
Journal:  J Obstet Gynaecol Br Commonw       Date:  1965-04

Review 2.  New concepts in dysmenorrhea.

Authors:  O Ylikorkala; M Y Dawood
Journal:  Am J Obstet Gynecol       Date:  1978-04-01       Impact factor: 8.661

3.  Reduction of mefenamic acid of increased menstrual blood loss associated with intrauterine contraception.

Authors:  J Guillebaud; A B Anderson; A C Turnbull
Journal:  Br J Obstet Gynaecol       Date:  1978-01

4.  Mefenamic acid in dysmenorrhea.

Authors:  M O Pulkkinen; H L Kaihola
Journal:  Acta Obstet Gynecol Scand       Date:  1977       Impact factor: 3.636

5.  Sodium flufenamate antagonises the potentiation by prostaglandins of noradrenaline-induced vasoconstriction in rat mesentery [proceedings].

Authors:  A Bennett; M A Carroll; G J Sanger
Journal:  Br J Pharmacol       Date:  1979-07       Impact factor: 8.739

6.  Anti-prostglandin therapy in prevention of side-effects of intrauterine contraceptive devices.

Authors:  O Ylikorkala; A Kauppila; M Siljander
Journal:  Lancet       Date:  1978-08-19       Impact factor: 79.321

7.  Pharmacological activity of PGI2 and its metabolite 6-oxo-PGF1alpha on human uterus and fallopian tubes.

Authors:  C Omini; R Pasargiklian; G C Folco; M Fano; F Berti
Journal:  Prostaglandins       Date:  1978-06

8.  Trial of prostaglandin-synthetase inhibitors in primary dysmenorrhoea.

Authors:  A B Anderson; P J Haynes; I S Fraser; A C Turnbull
Journal:  Lancet       Date:  1978-02-18       Impact factor: 79.321

9.  Flufenamic acid in treatment of primary spasmodic dysmenorrhoea. A double-blind crossover study.

Authors:  L Kapadia; M G Elder
Journal:  Lancet       Date:  1978-02-18       Impact factor: 79.321

10.  Determination of menstrual prostaglandin levels in non-dysmenorrheic and dysmenorrheic subjects.

Authors:  W Y Chan; J C Hill
Journal:  Prostaglandins       Date:  1978-02
View more
  3 in total

1.  Antagonism of prostanoid-induced contractions of rat gastric fundus muscle by SC-19220, sodium meclofenamate, indomethacin or trimethoquinol.

Authors:  A Bennett; C Jarosik; G J Sanger; D E Wilson
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

2.  Antagonism by fenamates of prostaglandin action in guinea-pig and human alimentary muscle.

Authors:  A Bennett; D Pratt; G J Sanger
Journal:  Br J Pharmacol       Date:  1980-03       Impact factor: 8.739

3.  Structure-activity relationship of fenamates as Slo2.1 channel activators.

Authors:  Priyanka Garg; Michael C Sanguinetti
Journal:  Mol Pharmacol       Date:  2012-07-31       Impact factor: 4.436

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.